רקומבינאט IU 500

Ország: Izrael

Nyelv: héber

Forrás: Ministry of Health

Aktív összetevők:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Beszerezhető a:

TEVA MEDICAL MARKETING LTD.

ATC-kód:

B02BD05

Gyógyszerészeti forma:

POWDER FOR SOLUTION FOR INJECTION

Az alkalmazás módja:

I.V

Gyártó:

BAXTER S.A., BELGIUM

Terápiás csoport:

COAGULATION FACTOR VII

Terápiás javallatok:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Engedély dátuma:

2010-07-01